11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

Garcia, J R; Jorcano, S; Soler, M; Linero, D; Moragas, M; Riera, E; Miralbell, Raymond; Lomeña, F

Scientific article

English

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

ContributorsGarcia, J R; Jorcano, S; Soler, M; Linero, D; Moragas, M; Riera, E; Miralbell, Raymond; Lomeña, F

Published inThe Quarterly journal of nuclear medicine and molecular imaging, vol. 59, no. 3, p. 342-350

Publication date2015

Abstract

Aim of the present study was to evaluate the usefulness of 11C-choline PET/CT for detecting lymphatic or haematogenous spread and for planning radiotherapy in patients with medium-to-high risk prostate cancer.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Groupe Miralbell Raymond (radio-oncologie) (685)

Citation (ISO format)

GARCIA, J R et al. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning. In: The Quarterly journal of nuclear medicine and molecular imaging, 2015, vol. 59, n° 3, p. 342–350.

Identifiers

PID : unige:75421
PMID : 24844254

Journal ISSN1824-4785

563views

0downloads

Creation22/12/2014 16:37:00

First validation22/12/2014 16:37:00

Update time14/03/2023 23:38:18

Status update14/03/2023 23:38:18

Last indexation31/10/2024 01:19:52

Archive ouverte UNIGE

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

Aim of the present study was to evaluate the usefulness of 11C-choline PET/CT for detecting lymphatic or haematogenous spread and for planning radiotherapy in patients with medium-to-high risk prostate cancer.

Technical informations